Global Health Limited (NSE:MEDANTA)

Global Health Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	387,148	258,334	321,848	354,739	141,325	-
Market Cap Growth	21.66%	-19.73%	-9.27%	151.01%	-	-
Enterprise Value	386,864	255,607	318,916	352,943	146,758	-
Last Close Price	1439.70	960.76	1197.44	1320.21	526.57	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	62.71	46.43	66.85	74.18	43.34	-
Forward PE	45.20	39.25	52.37	59.16	39.58	-
PS Ratio	7.66	5.86	8.72	10.83	5.22	-
PB Ratio	8.91	6.48	9.50	12.21	5.82	-
P/TBV Ratio	9.00	6.55	9.54	12.23	5.83	-
P/FCF Ratio	204.78	-	300.19	106.37	34.59	-
P/OCF Ratio	40.60	36.16	51.60	57.96	21.93	-
PEG Ratio	1.87	1.95	2.69	1.91	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	7.66	5.80	8.64	10.78	5.42	-
EV/EBITDA Ratio	34.57	28.59	37.29	45.20	23.72	-
EV/EBIT Ratio	45.23	36.44	46.55	56.04	30.30	-
EV/FCF Ratio	204.63	-	297.46	105.83	35.92	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.31	0.30	0.21	0.28	0.46	0.69
Debt / EBITDA Ratio	1.21	1.29	0.82	1.00	1.78	2.40
Debt / FCF Ratio	7.16	-	6.69	2.40	2.75	30.15
Net Debt / Equity Ratio	-0.01	0.02	-0.10	-0.12	-0.06	0.38
Net Debt / EBITDA Ratio	-0.04	0.09	-0.39	-0.45	-0.22	1.39
Net Debt / FCF Ratio	-0.25	-0.68	-3.11	-1.06	-0.34	16.88
Asset Turnover	0.84	0.83	0.81	0.78	0.75	0.74
Inventory Turnover	30.15	30.00	26.53	24.50	23.03	24.17
Quick Ratio	2.50	2.47	2.22	2.27	2.59	1.69
Current Ratio	2.72	2.67	2.48	2.44	2.76	1.94
Return on Equity (ROE)	15.23%	15.03%	15.30%	17.93%	16.13%	13.09%
Return on Assets (ROA)	8.90%	8.22%	9.44%	9.35%	8.34%	7.16%
Return on Invested Capital (ROIC)	15.43%	15.26%	18.17%	19.84%	15.53%	10.90%
Return on Capital Employed (ROCE)	14.70%	13.30%	16.50%	17.10%	13.70%	12.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.59%	2.15%	1.50%	1.35%	2.31%	-
FCF Yield	0.49%	-0.48%	0.33%	0.94%	2.89%	-
Dividend Yield	0.03%	0.05%	0.04%	-	-	-
Payout Ratio	3.78%	2.42%	-	-	-	-
Buyback Yield / Dilution	-0.14%	-0.27%	-	-3.52%	-2.81%	-0.13%
Total Shareholder Return	-0.10%	-0.21%	0.04%	-3.52%	-2.81%	-0.13%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error